Veos Pharmaceuticals, SL

Veos Pharmaceuticals is a circular biotech company developing nature-based solutions for air purification, emissions reduction, sustainable water and soil regeneration, and aging.

Our flagship platform, OliQuell™, is a patented, biodegradable powder derived from olive-waste and functional bioactives. It passively reduces CO₂, H₂S, VOCs, and odors in closed systems such as HVAC filters, EV cabins, biogas digesters, and irrigation water—without the need for active energy input or infrastructure changes.

OliQuell™ is validated in automotive, agriculture, and wastewater treatment settings, including a recent Volvo trial showing up to 45% CO₂ inhibition under sealed recirculation. It is fully compatible with circular and CCUS strategies.

Veos is GMP-compliant, IP-protected, and actively operating in the EU, North America, and now expanding into Japan and Korea through pilot partnerships and OEM integrations in energy, smart mobility, and water reuse.